Close button
Enquiry IconContact Us
Logo
  • Choose License Type

Global Intraosseous Infusion Devices Market, by Product Type (FAST1 Device, FASTx Device, Bone Injection Gun (BIG) Devices, EZ-IO Device, NIO Device, Dieckmann Modified Needle, and Jamshidi Needle), by Technology (Manual IO Needles, Battery Powered Driver, and Impact Driven Devices), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others (Pre-hospital Emergency Care, Military Hospitals)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 916.9 Mn in 2021 and is expected to exhibit a CAGR of 5.3% during the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.

Increasing launches of technologically advanced products are expected to propel growth of the global intraosseous infusion devices market over the forecast period. For instance, on March 02, 2020, SAM Medical, an industry leader and innovator in emergency medical supplies, field treatment, and first aid, announced the launch of SAM IO an intraosseous access system. The system was meant for use in hospital and pre-hospital healthcare providers in military and civilian sectors. The SAM IO's unique multi-use driver and manually powered device offers medical professionals the ability to easily and quickly administer critical fluids and medications into a patient's vascular system during emergency situations through the bone marrow.

Global intraosseous Infusion Devices Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdown in various countries across the globe has impacted the financial status of businesses across all sectors including private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. It has affected the economy of various regions across the globe in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; and 3) through its financial impact on companies and financial markets. Several countries such as Thailand, Indonesia, and Singapore are facing problems with regards to transportation and distribution of healthcare products. For instance, according to the Journal of Health Management, August 11, 2020, China being the epicenter of COVID-19, it went under a lockdown and extensive measures were put into action quite early, causing supply from the manufacturing facilities being reduced, affecting the exports from China and imports to the other countries.

Browse 38 Market Data Tables and 36 Figures spread through 193 Pages and in-depth TOC on “Global Intraosseous Infusion Devices Market”-  Forecast to 2028, Global Intraosseous Infusion Devices Market, by Product Type (FAST1 Device, FASTx Device, Bone Injection Gun (BIG) Devices, EZ-IO Device, NIO Device, Dieckmann Modified Needle, and Jamshidi Needle), by Technology (Manual IO Needles, Battery Powered Driver, and Impact Driven Devices), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others (Pre-hospital Emergency Care, Military Hospitals)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the Intraosseous Infusion Devices Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/intraosseous-infusion-devices-market-507

Moreover, regulatory approvals for intraosseous infusion devices are also expected to aid in growth of the global intraosseous infusion devices market over the forecast period. For instance, in November 2019, PerSys Medical, a global entity specialized in the development and marketing of innovative medical devices, announced that it had received the U.S. Food and Drug Administration (FDA) approval for NIO Infant. The NIO Infant is a manual intraosseous (IO) access device that administers medications and intravascular fluids through the proximal tibia as an alternative to IV administration during emergency medical situations.

Key Takeaways of the Global Intraosseous Infusion Devices Market:

  • The global intraosseous infusion devices market is expected to exhibit a CAGR of 5.3% during the forecast period due to rising merger collaborations and acquisitions by pharmaceutical companies, which is expected to boost growth of the market. For instance, in May 2019, Argon Medical Devices, Inc., a global manufacturer of specialty medical products, headquartered in Frisco, Texas, acquired Mana-Tech, Ltd., an exclusive distributor of medical devices for Ireland and the U.K. The acquisition of Mana-Tech, Ltd helped in expanding its market presence in Ireland, the U.K., and throughout Europe.
  • On the basis of technology, battery powered driver segment is estimated to hold a dominant position in the global intraosseous infusion devices market in 2021. Battery powered driver are easy to use and require less training. Battery powered drills enable a broader range of access points to the injection site. They consist of a reusable drill and disposable needles. Such advantages offered by battery powered drivers is expected to drive the demand for battery powered drivers from medical professionals.
  • Among regions, North America is estimated to account for the largest market share the in global intraosseous infusion devices market in 2021, owing to the rising prevalence of diseases and trauma injury cases which is expected to drive the intraosseous infusion devices market growth in the near future. For instance, according to the American Heart Association report, the age-adjusted death rate attributable to cardiovascular disease (CVD), based on 2017 data, is 219.4 per 100,000. On an average, someone dies of CVD every 37 seconds in the U.S. There are 2,353 deaths from CVD each day, in the U.S. based on 2017 data.
  • Major players operating in the global intraosseous infusion devices market include PerSys Medical, Aero Healthcare AU Pty Ltd, Teleflex Incorporated, PAVmed Inc., BIOPSYBELL S.R.L., Becton Dickinson Company, Cook Group, SAM Medical, Argon Medical Devices, Inc., Cardinal Health, Inc., StarFish Product Engineering Inc., and Medax SRL unipersonle
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly subscribe for our latest news & articles.